Plasma proteomics analysis of tamoxifen resistance in breast cancer

Majidzadeh-A, Keivan; Gharechahi, Javad
December 2013
Medical Oncology;Dec2013, Vol. 30 Issue 4, p1
Academic Journal
No abstract available.


Related Articles

  • Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.  // Breast Cancer Research;2012, Vol. 14 Issue 1, p3144 

    The article focuses on a study that determines the global proteomic changes in a tamoxifen resistant MCF-7 breast cancer cell line that are cultivated by long term treatment of MCF-7 cell line with 4-hydroxytamoxifen (4-OH Tam). A wide breadth of signaling events during transition to acquired...

  • Poster Session II (Statler): Proteomics.  // Journal of Extracellular Vesicles;2013, Vol. 2, p43 

    The article presents abstracts on topics related to protemics including proteomic analysis of exosomes, proteomic analysis of drug resistant and breast-cancer derived microparticles, and the effect on the proteomic landscape of microparticles of over-expression of a single oncogene.

  • Tamoxifen in the treatment of breast cancer. Legha, Sewa Singh; Legha, S S // Annals of Internal Medicine;8/1/88, Vol. 109 Issue 3, p219 

    Tamoxifen, an antiestrogen, is a competitive inhibitor of estradiol, blocking its effects on the target organs. During the 10 years it has been used in the United States it has become preferred over estrogens for treating postmenopausal women with metastatic breast cancer. Recently, tamoxifen...

  • Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth. Catalano, Stefania; Giordano, Cinzia; Panza, Salvatore; Chemi, Francesca; Bonofiglio, Daniela; Lanzino, Marilena; Rizza, Pietro; Romeo, Francesco; Fuqua, Suzanne; Maggiolini, Marcello; Andò, Sebastiano; Barone, Ines // Breast Cancer Research & Treatment;Jul2014, Vol. 146 Issue 2, p273 

    Tamoxifen resistance is a major clinical challenge in breast cancer treatment. Aromatase inhibitors are effective in women who progressed or recurred on tamoxifen, suggesting a role of local estrogen production by aromatase in driving tamoxifen-resistant phenotype. However, the link between...

  • Erratum to, "Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival Tamoxifen Resistance" published in Neoplasia Volume, 16 number 5 on pages 390-402.  // Neoplasia;Aug2014, Vol. 16 Issue 8, p678 

    A correction to the article "Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival Tamoxifen Resistance," published in the May 2014 issue of "Neoplasia" is presented.

  • Statistical analysis of array expression data as applied to the problem of tamoxifen resistance. Hilsenbeck, Susan G.; Friedrichs, William E.; Schiff, Rachel; O'Connell, Peter; Hansen, Rhonda K.; Osborne, C. Kent; Fuqua, Suzanne A. W.; Hilsenbeck, S G; Friedrichs, W E; Schiff, R; O'Connell, P; Hansen, R K; Osborne, C K; Fuqua, S A // JNCI: Journal of the National Cancer Institute;03/03/99, Vol. 91 Issue 5, p453 

    Background: Although the emerging complementary DNA (cDNA) array technology holds great promise to discern complex patterns of gene expression, its novelty means that there are no well-established standards to guide analysis and interpretation of the data that it produces. We have...

  • Cancer Research: Possible therapy for tamoxifen resistant breast cancer identified.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article offers information on a study which discusses the proliferation of tamoxifen-resistant breast-cancer.

  • Erratum.  // Oncology;2019, Vol. 97 Issue 4, p254 

    A correction to the article "Overcoming Tamoxifen Resistance by Regulation of Del-1 in Breast Cancer" is presented.

  • Nuclear receptors: Growing concern for tamoxifen. Owens, Joanna // Nature Reviews Drug Discovery;Aug2004, Vol. 3 Issue 8, p647 

    Reports on the result of the study addressing tamoxifen resistance in breast cancer treatment. Mechanism underlying cyclic adenylic acid-induced resistance; Role of the protein kinase A pathway; Implications for improving the success rate of tamoxifen treatment.

  • Med1 plays a critical role in the development of tamoxifen resistance. Nagalingam, Arumugam; Tighiouart, Mourad; Ryden, Lisa; Joseph, Leena; Landberg, Goran; Saxena, Neeraj K.; Sharma, Dipali // Carcinogenesis;Apr2012, Vol. 33 Issue 4, p918 

    Understanding the molecular pathways that contribute to the development of tamoxifen resistance is a critical research priority as acquired tamoxifen resistance is the principal cause of poor prognosis and death of patients with originally good prognosis hormone-responsive breast tumors. In this...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics